Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.4001
Delayed Data
As of Jul 24
 0.0001 / +0.02%
Today’s Change
0.31
Today|||52-Week Range
1.10
-25.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.7M

Company Description

Oragenics, Inc. is a biopharmaceutical company. The company is focused on developing novel antibiotics against infectious disease and treatments for oral mucositis. It also develops, markets, and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Contact Information

Oragenics, Inc.
4902 Eisenhower boulevard
Tampa Florida 33634
P:(813) 286-7900
Investor Relations:

Employees

Shareholders

Individual stakeholders49.91%
Other institutional4.31%
Mutual fund holders4.12%

Top Executives

Alan F. JoslynPresident, Chief Executive Officer & Director
Michael O'Keefe SullivanChief Financial Officer, Secretary & Treasurer
Martin HandfieldSenior Vice President-Discovery Research